Human Investing’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.35M | Sell |
9,340
-129
| -1% | -$27.8K | 0.3% | 28 |
|
|
2026
Q1 | $2.06M | Sell |
9,469
-667
| -7% | -$148K | 0.3% | 28 |
|
|
2025
Q4 | $2.32M | Sell |
10,136
-644
| -6% | -$147K | 0.33% | 28 |
|
|
2025
Q3 | $2.5M | Sell |
10,780
-2,251
| -17% | -$458K | 0.37% | 26 |
|
|
2025
Q2 | $2.42M | Sell |
13,031
-42
| -0.3% | -$7.81K | 0.38% | 26 |
|
|
2025
Q1 | $2.74M | Sell |
13,073
-352
| -3% | -$68.4K | 0.48% | 26 |
|
|
2024
Q4 | $2.39M | Sell |
13,425
-297
| -2% | -$54.6K | 0.42% | 26 |
|
|
2024
Q3 | $2.71M | Buy |
13,722
+74
| +0.5% | +$13.8K | 0.49% | 27 |
|
|
2024
Q2 | $2.34M | Sell |
13,648
-1,139
| -8% | -$189K | 0.46% | 29 |
|
|
2024
Q1 | $2.69M | Sell |
14,787
-52
| -0.4% | -$8.96K | 0.54% | 27 |
|
|
2023
Q4 | $2.3M | Sell |
14,839
-747
| -5% | -$109K | 0.5% | 27 |
|
|
2023
Q3 | $2.32M | Buy |
15,586
+57
| +0.4% | +$8.37K | 0.54% | 24 |
|
|
2023
Q2 | $2.09M | Sell |
15,529
-2,920
| -16% | -$428K | 0.48% | 26 |
|
|
2023
Q1 | $2.94M | Sell |
18,449
-1,404
| -7% | -$215K | 0.71% | 21 |
|
|
2022
Q4 | $3.21M | Sell |
19,853
-3,154
| -14% | -$484K | 0.82% | 18 |
|
|
2022
Q3 | $3.09M | Sell |
23,007
-683
| -3% | -$98K | 0.79% | 20 |
|
|
2022
Q2 | $3.63M | Sell |
23,690
-738
| -3% | -$113K | 0.88% | 20 |
|
|
2022
Q1 | $3.96M | Sell |
24,428
-5,807
| -19% | -$844K | 0.88% | 20 |
|
|
2021
Q4 | $4.09M | Sell |
30,235
-535
| -2% | -$63.2K | 0.98% | 19 |
|
|
2021
Q3 | $3.32M | Sell |
30,770
-586
| -2% | -$67K | 0.78% | 19 |
|
|
2021
Q2 | $3.53M | Buy |
31,356
+214
| +0.7% | +$24.1K | 0.86% | 19 |
|
|
2021
Q1 | $3.37M | Sell |
31,142
-3,705
| -11% | -$396K | 0.86% | 18 |
|
|
2020
Q4 | $3.73M | Sell |
34,847
-8,585
| -20% | -$825K | 1.06% | 17 |
|
|
2020
Q3 | $3.8M | Sell |
43,432
-3,657
| -8% | -$344K | 1.25% | 13 |
|
|
2020
Q2 | $4.62M | Sell |
47,089
-3,067
| -6% | -$270K | 1.63% | 12 |
|
|
2020
Q1 | $3.82M | Sell |
50,156
-6,872
| -12% | -$585K | 1.65% | 10 |
|
|
2019
Q4 | $5.05M | Sell |
57,028
-1,053
| -2% | -$87.4K | 1.65% | 9 |
|
|
2019
Q3 | $4.4M | Sell |
58,081
-95
| -0.2% | -$6.51K | 1.56% | 10 |
|
|
2019
Q2 | $4.23M | Sell |
58,176
-462
| -0.8% | -$36.3K | 1.54% | 10 |
|
|
2019
Q1 | $4.73M | Buy |
58,638
+28,300
| +93% | +$2.32M | 1.77% | 9 |
|
|
2018
Q4 | $2.8M | Buy |
+30,338
| New | +$2.67M | 1.17% | 19 |
|
Other funds holding ABBV
Human Investing's ABBV Position: Q2 2026 in Review
Human Investing reduced its AbbVie (ABBV) stake by 1.4% in Q2 2026, selling an estimated $27.8K and leaving 9,340 shares worth $2.35M. The position accounts for 0.3% of the portfolio, ranked #28.
Human Investing first reported a position in ABBV in Q4 2018 and has held it in 31 quarters since. The position peaked at $5.05M in Q4 2019. 4,225 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Human Investing held 9,340 shares of AbbVie worth $2.35M as of Q2 2026.
- Human Investing sold 129 AbbVie shares in Q2 2026, an estimated $27.8K.
- AbbVie made up 0.3% of Human Investing's portfolio in Q2 2026, its #28 holding.
- Human Investing first reported a position in AbbVie in Q4 2018 and has held it in 31 quarters since.
- Human Investing's AbbVie position peaked at $5.05M in Q4 2019.
- 4,225 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Human Investing's 13F filing for Q2 2026, filed 20 Jul 2026.